USRD
Themes US R&D Champions ETF
The Themes US R&D Champions ETF aims to provide investors with exposure to U.S. companies that prioritize research and development, driving innovation and economic growth.
US
EQUITY
Passive
MANAGEMENT STYLE
1.0 M
ASSETS UNDER MGMT
29 bp
EXPENSES
Fund Basics
| Fund sponsor | Themes |
| Category | US |
| Asset class | Equity |
| Website | link... |
| Inception date | Dec 12, 2023 |
| Assets (mns) | $1 |
| Expense ratio | 29 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | |
| Taxation | 1099 |
| Stock selection | |
| Weighting | |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| LAM RESEARCH CORP | 2.8 % |
| APPLIED MATERIALS INC | 2.6 % |
| ELI LILLY & CO | 2.5 % |
| REGENERON PHARMACEUTICALS | 2.5 % |
| KENVUE, INC. | 2.4 % |
| ALPHABET INC. CLASS A | 2.4 % |
| TEXAS INSTRUMENTS INC | 2.4 % |
| SYNOPSYS INC | 2.4 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 2.3 % |
| KEYSIGHT TECHNOLOGIES INC | 2.3 % |
Constituent Breakdown
| Number of holdings | 50 |
| Herfindahl-Hirschman Index | 202 |
| Wgt avg mkt cap (mns) | $485,471 |
| Large cap (>$10bn) | 99.8% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 98.1% |
| Emerging mkts. | 1.7% |
Country Exposure
 |
UNITED STATES | 96.5 % |
 |
ARGENTINA | 1.9 % |
 |
BRITAIN | 1.3 % |
Historical Performance
Standardized Performance (as of 12/31/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 12.0% | 12.0% | 12.4% | -- | -- | -- | -- | 14.1% |
| Dividend Yield | 0.5% | 0.5% | 1.6% | -- | -- | -- | -- | 1.6% |
| Total Returns | 12.4% | 12.4% | 14.0% | -- | -- | -- | -- | 15.6% | Ann. Volatility | 22.0% | 22.0% | 19.2% | -- | -- | -- | -- | 19.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.08 | 90% |
| MSCI EAFE | 1.03 | 60% |
| MSCI Emg Mkts | 0.98 | 62% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.20% |
Technical Indicators
| 30d moving avg. (EMA) | $33.59 |
| Relative strength (RSI) | 54 |
| MACD/Signal | 0.11/0.07 |
| Bollinger Bands (Upper/Lower) | $34.23/$32.90 |
| Short interest (% of AUM) | 0.0% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. USRD |
Expenses vs. USRD |
ALTAR Score™ vs. USRD |
|---|---|---|---|---|
| QQEW | First Trust Nasdaq-100 Equal Weighted Index Fund | 44.7% | +29 bp | +3.7% |
| DRUP | GraniteShares Nasdaq Select Disruptors ETF | 43.2% | +31 bp | +4.0% |
| QTEC | First Trust NASDAQ-100 Technology Sector Index Fund | 39.5% | +28 bp | +3.7% |
| QQQG | Pacer Nasdaq 100 Top 50 Cash Cows Growth Leaders ETF | 38.2% | +20 bp | +3.9% |
| XNTK | State Street SPDR NYSE Technology ETF | 36.3% | +6 bp | +3.4% |
| RSPT | Invesco S&P 500 Equal Weight Technology ETF | 36.0% | +11 bp | +5.1% |
| XPND | First Trust Expanded Technology ETF | 35.2% | +36 bp | +3.5% |
| XLK | The Technology Select Sector SPDR Fund | 30.8% | -21 bp | +4.3% |
| DFNV | Donoghue Forlines Innovation ETF | 30.4% | +40 bp | +4.8% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 30.2% | +11 bp | +3.6% |
Risk and Returns: USRD vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 1/11/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
UNDERWEIGHT
Below average appreciation potential. A rating of UNDERWEIGHT is assigned to ETFs with ALTAR Scores in the 2nd quintile (ranking higher than only 20%-40%) of their category. Typically, funds in this category consist of stocks trading at relatively expensive valuations and/or having below-average fundamentals.
ALTAR Score™
USRD
4.5%
Cat. Avg
5.5%
ALTAR Score™ Calculation
Category Overview
There are 1045 funds in the US Equity category, with an average ALTAR Score™
of 5.5% and a standard deviation of
2.2%. USRD's ALTAR Score™ is approximately
0.4 standard deviations
below
the category average. This places USRD in the 33rd percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
USRDSELL
U/W
HOLD
O/W
BUY